EDAP TMS Pre-Announces Strong 98% Growth in HIFU sales in the Second Quarter 2019
July 25, 2019 08:00 ET
|
EDAP TMS S.A.
45% growth in total Q2 2019 revenue year-over-year 78% growth in HIFU sales year-to-date through June 30, 2019 Company to Report Second Quarter 2019 Financial Results on Wednesday, August 28, 2019 and...
Top Medical Centers Awarded da Vinci(R) Technology Grants for Robotic Surgery Simulation Practice
November 13, 2014 08:30 ET
|
Intuitive Surgical, Inc.
SUNNYVALE, Calif., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Intuitive Surgical (Nasdaq:ISRG) has awarded technology grants to five top U.S. medical centers to increase training opportunities in minimally...
Intuitive Surgical Receives FDA Clearance for First Single-Site(R) Wristed Needle Driver for da Vinci(R) Si(R) Surgical System
September 29, 2014 08:30 ET
|
Intuitive Surgical, Inc.
SUNNYVALE, Calif., Sept. 29, 2014 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (Nasdaq:ISRG) today announced that it has received U.S. Food and Drug Administration (FDA) clearance for the Single-Site...
FDA Clears da Vinci(R) System Use in Benign Base of Tongue Resection Procedures
September 18, 2014 08:30 ET
|
Intuitive Surgical, Inc.
SUNNYVALE, Calif., Sept. 18, 2014 (GLOBE NEWSWIRE) -- Intuitive Surgical (Nasdaq:ISRG) today announced that it has received FDA clearance for use of the da Vinci S® and da Vinci Si® Surgical...
Ten-Fold Growth in Surgeons Trained in Minimally Invasive da Vinci(R) Colorectal Surgery
September 04, 2014 13:51 ET
|
Intuitive Surgical, Inc.
SUNNYVALE, Calif., Sept. 4, 2014 (GLOBE NEWSWIRE) -- A record number of U.S. colorectal surgeons received hands-on training using the da Vinci Surgical System at the fourth-annual Colorectal...
Intuitive Surgical Receives Firefly(TM) FDA Clearance for da Vinci(R) Xi(TM) Surgical System
August 21, 2014 12:58 ET
|
Intuitive Surgical, Inc.
SUNNYVALE, Calif., Aug. 21, 2014 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (Nasdaq:ISRG), the global leader in robot-assisted minimally invasive surgery, today announced the FDA clearance of...